Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 32, 2021 - Issue 4
Submit an article Journal homepage
99
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Letter to the editor submitted in response to “efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial”

Emma AxonCentre of Evidence Based Dermatology, University of Nottingham, Nottingham, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3246-9968
ORCID Icon &
Douglas J. GrindlayCentre of Evidence Based Dermatology, University of Nottingham, Nottingham, UKORCID Iconhttps://orcid.org/0000-0002-0992-7182
ORCID Icon
Page 410 | Received 15 Aug 2019, Accepted 17 Aug 2019, Published online: 02 Sep 2019
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Letter to the editor submitted in response to “efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial”." Journal of Dermatological Treatment, 32(4), p. 410

Disclosure statement

The authors report no conflict of interest.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later
PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.